We are live on ! Find out more
ALT icon

Altimmune
ALT

36 hedge funds and large institutions have $28.3M invested in Altimmune in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more call options, than puts

Call options by funds: $151K | Put options by funds: $47K

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

8% less funds holding

Funds holding: 39 → 36 (-3)

22% less capital invested

Capital invested by funds: $36.2M → $28.3M (-$7.9M)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
2
Increased
12
Reduced
9
Closed
5
Calls
$151K
Puts
$47K
Net Calls
+$104K
Net Calls Change
-$166K

Top Buyers

1
JCI
Jet Capital Investors
New York
+$618K
2
PCM
Potomac Capital Management
New York
+$151K
3
Morgan Stanley
Morgan Stanley
New York
+$86.3K
4
PCM
Perkins Capital Management
Minnesota
+$79.1K
5
CCA
Catalyst Capital Advisors
New York
+$44.8K

Top Sellers

1
SC
Sophrosyne Capital
New York
-$335K
2
OAM
Oxford Asset Management
United Kingdom
-$179K
3
BIT
BlackRock Institutional Trust
California
-$98.6K
4
GMCM
Gruber & McBaine Capital Management
California
-$40.7K
5
Citadel Advisors
Citadel Advisors
Florida
-$40.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$8.95M – – –
PGCM
2
Prescott Group Capital Management
Oklahoma
$7.39M – – –
OTPPB
3
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.14M – – –
PCM
4
Perkins Capital Management
Minnesota
$2.09M +$79.1K +175 +4%
JCI
5
Jet Capital Investors
New York
$2.02M +$618K +1,366 +40%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.78M – – –
PCM
7
Potomac Capital Management
New York
$974K +$151K +333 +17%
GMCM
8
Gruber & McBaine Capital Management
California
$808K -$40.7K -90 -5%
BCM
9
Bridgeway Capital Management
Texas
$367K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$245K – – –
BFA
11
BlackRock Fund Advisors
California
$223K +$6.78K +15 +3%
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$162K – – –
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$161K -$32.1K -71 -16%
JGC
14
J. Goldman & Co
New York
$140K +$39.8K +88 +36%
Morgan Stanley
15
Morgan Stanley
New York
$120K +$86.3K +191 +208%
Northern Trust
16
Northern Trust
Illinois
$113K +$904 +2 +0.8%
Group One Trading
17
Group One Trading
Illinois
$97K -$28.9K -64 -22%
CCA
18
Catalyst Capital Advisors
New York
$92K +$44.8K +99 +84%
RCM
19
Rotella Capital Management
Washington
$71K +$31.6K +70 +74%
U
20
UBS
Switzerland
$67K -$1.81K -4 -2%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$60K +$452 +1 +0.7%
GC
22
Guggenheim Capital
Illinois
$39K -$4.07K -9 -9%
BIT
23
BlackRock Institutional Trust
California
$37K -$98.6K -218 -72%
Bank of America
24
Bank of America
North Carolina
$35K +$37.1K +82 New
State Street
25
State Street
Massachusetts
$26K – – –
1
2

ALT Hedge Fund Activity: Q2 2014 in Review

36 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2014, worth a combined $28.3M — down 22% from $36.2M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ALT and 2 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Jet Capital Investors, adding an estimated $618K. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $335K sold.

  • 36 institutional investors held Altimmune (ALT) as of Q2 2014, down from 39 in Q1 2014.
  • Funds reported $28.3M of Altimmune stock for Q2 2014, down 22% quarter-over-quarter.
  • 2 funds opened new Altimmune positions in Q2 2014 and 5 closed out, a net change of -3 holders.
  • The largest Altimmune buyer in Q2 2014 was Jet Capital Investors, an estimated $618K added.
  • The largest Altimmune seller in Q2 2014 was Sophrosyne Capital, an estimated $335K sold.

Based on aggregated 13F filings for Q2 2014.